Amino Acid Metabolism, Inborn Errors - 53 Studies Found

Active, not recruiting : Study of a National Cohort of Adult Patients With Phenylketonuria
:
  • PKU
  • Hyperphenylalaninemia

: 2012-06-12
Completed : Effects of Kuvan on Melatonin Secretion
: Phenylketonuria (PKU)
: 2012-06-08
:
  • Drug: Kuvan Dosed at 20 mg/kg;
Completed : A Study to Evaluate Subcutaneously Administered rAvPAL-PEG in Patients With Phenylketonuria for 24 Weeks
: Phenylketonuria
: 2012-03-05
: Biological: rAvPAL-PEG Subcutaneous injection of rAvPAL-PEG administered from 1 time up to 5 times per w
Terminated : Bone Mineral Density in Adults With Hyperphenylalaninemia on Kuvan Therapy
:
  • Hyperphenylalaninemia
  • Phenylketonuria

: 2011-07-11
: Drug: Sapropterin 20 mg/kg, orally, daily, 1 year or patient chooses to discontinue therapy
Completed : Phase 2 Study of Glycomacropeptide Versus Amino Acid Diet for Management of Phenylketonuria
: Phenylketonuria
: 2011-08-31
:
  • Other: GMP Diet/GMP Medical Foods

Withdrawn : Neuroimaging and Neurocognitive Assessment and Response to Sapropterin Dihydrochloride Treatment in Phenylketonuria
: PKU
: 2011-08-01
:
  • Dietary Supplement: diet 12 pa
Withdrawn : Evaluation of Behavior, Executive Function, Neurotransmitter Function and Genomic Expression Kuvan Nonresponders
:
  • Phenylketonuria
  • Behavior and Behavior Mechanisms
  • PAH Gene
    : 2011-01-10
    : Drug: sapropterin dihydrochloride In 30 PKU patients found
Completed : Bone Mineral Density in Adults With Hyperphenylalaninemia
: Phenylketonurias
: 2010-09-24
Completed : Follow-up of Adult Phenylketonuria (PKU) Patients
:
  • Nutritional Deficiencies
  • Phenylketonuria

: 2010-03-30
Completed : Dose-Finding Study to Evaluate the Safety, Efficacy, & Tolerability of Multiple Doses of rAvPAL-PEG in Subjects With PKU
: Phenylketonuria
: 2009-06-17
: Drug: rAvPAL-PEG In Part 1, the planned starting dose levels are those tested in PAL-001 (0.001, 0.003,
<<< Previous | Next >>>